|
MechanismSOD1 gene inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date25 Apr 2023 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date28 Feb 2023 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date29 Oct 2019 |
100 Clinical Results associated with Biogen Australia Pty Ltd.
0 Patents (Medical) associated with Biogen Australia Pty Ltd.
100 Deals associated with Biogen Australia Pty Ltd.
100 Translational Medicine associated with Biogen Australia Pty Ltd.